Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

APGE - Apogee Therapeutics Inc.

IEX Last Trade
51.31
1.880   3.664%

Share volume: 454,925
Last Updated: Fri 30 Aug 2024 10:00:00 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology): 0.21%

PREVIOUS CLOSE
CHG
CHG%
$49.43
1.88
3.80%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
4%
Profitability 0%
Dept financing 0%
Liquidity 0%
Performance 10%
Performance
5 Days
5.81%
1 Month
6.83%
3 Months
10.38%
6 Months
44.02%
1 Year
114.10%
2 Year
141.03%
Key data
Stock price
$51.31
P/E Ratio 
0.00
DAY RANGE
N/A - N/A
EPS 
$0.00
52 WEEK RANGE
$14.19 - $72.29
52 WEEK CHANGE
$1.07
MARKET CAP 
2.303 B
YIELD 
N/A
SHARES OUTSTANDING 
44.999 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/11/2024
BETA 
1.33
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$275,113
AVERAGE 30 VOLUME 
$350,389
Company detail
CEO:
Region: US
Website:
Employees: 0
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services

Recent news